Hunter Syndrome Webcast

Home About Membership News & Events Resources Forums

Hunter Syndrome Webcast

Shire Human Genetic Therapies invites you to participate in a Webcast discussion of the first approved biopharmaceutical treatment for Hunter syndrome and the pivotal Phase II/III clinical study data of ELAPRASE™ (idursulfase).

Click on the link below for more information.

Acrobat Document HunterSyndromeWebcast.pdf

News & Events

Garrod Symposium 2010

Annual SPDM Meeting, 29-30 October 2009, Portugal

Garrod Symposium 2009

Garrod Symposium 2008

2008 LSD Club Meeting

CRA tax exemption for low protein products

New faculty Position - Clinical and Metabolic Genetics - Hospital for Sick Children

Update from Global Organization for Lysosomal Diseases

Garrod Symposium 2007: Neurometabolic Disorders and Newborn Screening

Garrod Symposium 2006: Treatment of Metabolic Disease

Membership

Garrod Association Application Forms

Garrod Association Training

Resources

GAUCHER DISEASE: Canadian Guidelines for Treatment by Enzyme Replacement with Imiglucerase or Substrate Reduction Therapy with Miglustat (v.8, March 2007)

FABRY DISEASE: Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy in Canada (November 2005)

Resources On The Web

SSIEM Websites and Resources

Copyright (c) 2001-2009
Canadian Association of Centres for the Management of Hereditary Metabolic Diseases
Association Canadienne des Centres de Traitment pour les Maladies Metaboliques Hereditaires.